Language selection

Search

Patent 2055255 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2055255
(54) English Title: PROCESS FOR PREPARING NEOTREHALOSE AND ITS USES
(54) French Title: PROCEDE D'OBTENTION DE NOTREHALOSE, ET APPLICATIONS
Status: Deemed expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12P 19/14 (2006.01)
  • C12P 19/18 (2006.01)
(72) Inventors :
  • MIWA, YOSHIKATSU (Japan)
  • SHIBUYA, TAKASHI (Japan)
  • CHAEN, HIROTO (Japan)
(73) Owners :
  • KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (Japan)
(71) Applicants :
(74) Agent: MACRAE & CO.
(74) Associate agent:
(45) Issued: 2002-09-03
(22) Filed Date: 1991-11-12
(41) Open to Public Inspection: 1992-05-16
Examination requested: 1998-08-12
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
307054/1990 Japan 1990-11-15

Abstracts

English Abstract





Neotrehalose is prepared in a relatively high-yield
by a process comprising allowing .beta.-galactosidase to act on a
solution containing lactoneotrehalose to form neotrehalose and
recoverying the resultant neotrehalose. The neotrehalose is a
non-reducing oligosaccharide having a satisfiable stability and
a rich- and high-quality-sweetness and is assimilated and
utilized as energy source in vivo when orally administered.
Neotrehalose in the form of crystal has a satisfiable
handleability because it is readily soluble in water and
substantially free of hygroscopicity. These render
neotrehalose very useful in the fields of food-, cosmetic- and
pharmaceutical-industries.


Claims

Note: Claims are shown in the official language in which they were submitted.




CLAIMS:

1. A process to prepare neotrehalose, which
comprises:
(a) allowing .beta.-galactosidase (EC 3.2.1.23) to act
on a solution containing lactoneotrehalose shown by the
formula O-.beta.-D-galactopyranosyl-(1-4)-O-.beta.-D-glucopyranosyl .alpha.-D-
glucopyranoside to form neotrehalose; and
(b) recovering the resultant neotrehalose.
2. The process of claim 1, wherein the step (b)
contains a step of subjecting the resultant solution in the
step (a) to a column chromatography using a strongly-acidic
cation exchange resin.
3. The process of claim 1, wherein the concentration
of lactoneotrehalose in said solution in the step (a) is in the
range of about 5-50 w/w %.
4. The process of claim 1, wherein the step (a) is
effected at a temperature in the range of 20-80°C and a pH in
the range of 3-9.
5. A process to prepare crystalline neotrehalose,
which comprises:
(a) allowing .beta.-galactosidase (EC 3.2.1.23) to act
on a solution containing lactoneotrehalose shown by the formula
O-.beta.-D-galactopyranosyl-(1-4)-O-.beta.-D-glucopyransyl .alpha.-D-
glucopyranoside to form neotrehalose;
(b) purifying and concentrating the resultant

-48-



solution into a supersaturated solution of neotrehalose to effect
crystallization of neotrehalose; and
(c) recovering the resultant crystalline
neotrehalose.
6. The process of claim 5, wherein the purity of the
resultant crystalline neotrehalose is at least 99.8 w/w %.
7. The process of claim 5, wherein the purification
and concentration in the step (b) is effected by subjecting the
resultant solution in the step (a) to a column chromatography
using a strongly-acidic cation exchange resin, recovering a
neotrehalose-rich fraction, and concentrating the fraction.
8. The process of claim 5, wherein the concentration
of lactoneotrehalose in said solution in the step (a) is in the
range of about 5-50 w/w %.
9. The process of claim 5, wherein the step (a) is
effected at a temperature in the range of 20-80°C and a pH in the
range of 3-9.
10. The process of claim 5, wherein the saturation
degree of the supersaturated solution is in the range of about
1.05-4Ø
11. The process of claim 5, wherein the step (b) is
effected at a temperature in the range of about 10-120°C.
12. In a process to prepare an orally-administrable
product containing neotrehalose, the improvement wherein said
neotrehalose is prepared by the process of claim 1.
13. In a process to prepare an orally-administrable
product containing neotrehalose, the improvement wherein said
neotrehalose is prepared by the process of claim 5.

-49-

Description

Note: Descriptions are shown in the official language in which they were submitted.


2~3~7~5~+
PROCESS FOR PREPARING NEO'.CREHALOSE AND ITS USES
Background of tlae Invention
1. Field of the invention
The present invention relates to a preparation of
neotrehalose and its uses, more particularly, it relates to a
preparation of neotrehalose comprising allowing S-galactosidase
(EC 3.2.1.23) to act on an aqueous solution containing
lactoneotrehalose and recoverying the resultant neotrehalose,
as well as to orally-administrable products containing said
neotrehalose.
2. Description of the prior art
Neotrehalose, which is a disaccharide shown by the
formula 0-a-D-glucopyranosyl S-D-glucopyranoside or 0-S-D-
glucopyranosyl a-D-glucopyranoside, has been known fox long.
Neotrehalose has a sweetness, non-reducibility, satisfiable
stability, and high water-solubility, and these merits would
render neotrehalose very useful in the preparations of orally-
administrable products, for example, foods, beverages,
cigarettes and tobaccos.
Although methods to prepare neotrehalose, for
example, those using chemical syntheses as reported in W. N.
Haworth et al., Journal of the Chemical Societ , pp.2gC,7-2850
(I931), and in V. E. S. Sharp et al., ibid, pp.285-288 (1951),
have been known, the yield of neotrehalose is extremely low and
-1-

CA 02055255 2001-04-25
there exist many problems which should be overcome in view of
the safeness, prior to actual use.
The prepG;rations of neotrehalose from natural
substances with a higher safeness or those by using biochemical
syntheses have been proposed. For example, K. Matsuda reported
in Journal of the Agricultural Chemical Society of Japan,
Vo1.30, No.2, pp.119-123 (1959) that a small amount of
neotrehalose was present in a koji extract together with
isomaltose and kojib:lose. In this report, neotrehalose was ,
prepared by a method comprising subjecting a koji extract to a
column chromatography using activated charcoal to remove
non-fermenting saccharides in the extract, recovering
fractions containing disaccharides, treating the disaccharides
with phenylhydrazine, separating the resultant sediment to
obtain a filtrate, acetylating the saccharides in the filtrate
to form crystalline octaacetates of the disaccharides, and
deacetylating the crystalline octaacetates. S. Kobayashi et
al. disclosed in Japanese Patent Laid-Open No.216,492/88 a
method containing a step of allowing a cyclodextrin-forming
enzyme to act on amylaceous substance to form neotrehalose
together with centose. In this report, high-performance liquid
chromatography (HPLC) revealed that the reaction solution
contained 18.6X neotrehalose and 20.0 centose, and the paper
chromatography analysis revealed that the resultant
neotrehalose-rich fraction contained about 20x of nigerose,
kojibiose and isomaltose. S. Kobayahshi et al. also proposed a
-2-

CA 02055255 2001-04-25
method to prepare neotrehalose from the reaction solution
comprising heating the reaction solution to inactivate the
remaining cyclodextri.n-forming enzyme, adding to the resultant
solution glucoamylase and yeast at the same time to digest and
remove the forming glucose, removing the remaining yeast,
autoclaving the rE:sultant after the addition of sodium
hydroxide, neutralizing the resultant product, and recoverying
the resultant neotrehalose with column chromatography and/or
the sedimentation method using solvents. None of the methods
has not yet been industrially carried out because of the
following reasons: (i) The methods only produce neotrehalose
preparations with a :relatively low-content of neotrehalose; and
(ii) The purification steps required after the methods are
extremely complicated, and the yield of neotrehalose attained
thereby is relatively low.
Summary of the Invention
There has been a great demand for a preparation of
neotrehalose and its. uses, wherein said neotrehalose is used
with a high-safeness and readily prepared in a relatively-high
yield.
The present inventors have studied preparations of
neotrehalose by using biochemical syntheses.
As a resu7_t:, the present inventors discovered that
neotrehalose was readily formed in a relatively-high yield by
-3-

CA 02055255 2001-04-25
allowing S-galact:osidase (EC 3.2.1.23) to act on lactoneo-
trehalose, as material, shown by the formula 0-S-D-
galactopyranosyl-(l-~4)-0-S-D-glucopyranosyl a-D-glucopyranoside
which has been disclosed by the present inventors in Japanese Patent
Publication JP-B2-2896598 (March 12, 1999). Thus, the present
inventors accomplished the present invention. The present
inventors also found that neotrehalose was a saccharide which
was readily digestible in vivo based on the result of in vivo
test with a high-purity neotrehalose according to the present
invention, and accomplished its uses, i.e. orally-administrable
products containing neotrehalose.
Brief Description of the Accompanying Drawings
FIG.1 shows an infrared absorption spectrum of a
crystalline lactoneotrehalose specimen.
FIG.2 shows a microscopic photograph (x50) of a
crystalline lactoneotrehalose specimen.
FIG.3 shows a powder x-ray diffraction pattern of a
crystalline lactoneotrehalose specimen.
FIG.4 shows an infrared absorption spectrum of a
crystalline neotrehalose specimen.
FIG S shows a microscopic photograph (x125) of a
crystalline neotrehalose specimen.
FIG.6 shows a powder x-ray diffraction pattern of a
crystalline neotrehalose specimen.
-4-



Detailed Description of the Tnvention
The present invention relates to a preparation of
neotrehalose and its uses, more particularly, it relates to a
preparation of neotrehalose comprising allowing S-galactosidase
(EC 3.2.1.23) to act on an aqueous solution containing
lactoneotrehalose and recoverying the resultant neotrehalose,
as well as to orally-administrable products containing said
neotrehalose.
Lactoneotrehalose, as material, usable in the
invention will be described.
Although lactoneotrehalose may be formed. through
chemical syntheses, much more preferable are, from industrial
view point, biochemical processes wherein lactoneotrehalose is
advantageously formed by allowing a saccharide-transferring
enzyme to act on an aqueous solution containing lactose and
amylaceous substance.
Commercially-available lactoses can be used in the
invention. If necessary, crude lactose preparations such as
milk and milk serum wherein lactose is present can be used in
the invention.
The amylaceous substances advantageously usable in
the invention are, for example, gelatinized starch, liquefied
starch, solubilized starch, partial starch hydrolysate, and
saccharide-transferred amylaceous products.
Although the saccharide-transferring enzyme most
-5-


preferable in ttLe invention is cyclomaltodextrin
glucanotransferase (EC 2.4.1.19), a-glucosidase (EC 3.2.1.20)
can bE: also used in the invention.
In the case of using cyclomaltodextrin glucano-
transferase, those derived from microorganisms of the genera
Back and Klebsiella can be advantageously used.
The a-glucosidases usable in the invention are, for
example, those derived from microorganisms of the genera
Penicillium and Nucor.
Although any saccharide-transferring reaction can be
used in the invention, as long as lactoneotrehalose is formed
by the reaction, and usually, lactoneotrehalose is formed by
allowing either cyclomaltodextrin glucanotransferase or
a-glucosidase to act on an aqueous solution containing lactose
and amylaceous substance such as partial starch hydrolysate to
transfer the a-glucosyl residue of the amy7.aceous substance to
the glucosyl residue of lactose.
Among these saccharide-transferring reactions, the
method using cyclomaltodextrin glucanotransferase is generally
most favorable because it can attain a higher lactoneotrehalose
yield with cheaper amylaceous substances as saccharide donor.
In particular, the use of cyclomaltodextrin glucanotransferase
derived from Bacillus stearothermophilus is extremely favorable
from industrial view point because the cyclomaltodextrin
glucanotransferase can be allowed to act on substrate at a
relatively-high temperature, and this inhibits the retrograda-
-6-




~~~~~5~
Lion of amylaceous substance in a reaction solution and the
contamination of microorganisms, as well as facilitating the
saccharide-transferring reaction.
Tn this case, one or more units/g amylaceous
substance, preferably, 10-1,000 units/g amylaceous substance of
cyclomaltodextrin glucanotransferase is allowed to act on an
aqueous solution containing lactose together with amylaceous
substance such as gelatinized starch, liquefied starch,
amylodextrin, cyclodextrin and partial starch hydrolysate
having a dextrose equivalent (DE) of about 1-S0, for about
1-100 hours, preferably, for about 4-70 hours, to form
lactoneotrehalose together with oligosaccharides, for .example,
a-glycosyl lactoneotrehalose such as a-glucosyl lactoneo-
trehalose, a-maltosyl lactoneotrehalose, a-maltotriosyl lacto-
neotrehalose and a-maltotetraosyl lactoneotrehalose, wherein
one or more a-glucosyl residues are bound to lactoneotrehalose.
These oligosaccharides are then subjected to glucoamylase to
form and accumulate lactoneotrehalose, followed by recoverying
the accumulated lactoneotrehalose.
Replacement of glucoamylase with S-amylase leads to
the formation and accumulation of lactoneotrehalose, a-glucosyl
lactoneotrehalose and maltose.
The above saccharide-transferring reactions with or
without a hydrolytic reaction form a lactoneotrehalose-
containing solution containing usually about 5-40 w/w % (the
symbol "w/w %" will hereinafter be abbreviated as "%", if
-7-

CA 02055255 2001-04-25
specified otherwise) of lactoneotrehalose, on the dry solid
basis (hereinafter abbreviated as "d.s.b."), which is then
filtered and purified into liquid, prior to use. Such a liquid
may be concentrated, and if necessary, dried. into syrup or
solid.
In general, in order to augment the merits of lacto-
neotrehalose, a :solution containing lactoneotrehalose is
separated and purified into a high-lactoneotrehalose content
product, prior to use. Such separation and purification are
achievable, for example, with fermentation using yeast,
membrane filtration, fractional-sedimentation, crystallization
and/or column chromatography, as long as the concomitant
saccharides are removed therewith.
Since lact:oneotrehalose is readily crystallizable
from the concentrate of the high-lactoneotrehalose content
solution, crystalline lactoneotrehalose can be advantageously
prepared from the solution, prior to use.
Any method to prepare neotrehalose from a lactoneo-
trehalose obtained by the above methods can be used in the
invention, as long as neotrehalose is formed by allowing
B-galactosidase to act on the lactoneotrehalose.
S-Galactosidase is allowed to act on lactoneotrehalose by
adding (i-galactosidase to an aqueous solution containing
lactoneotrehalose and allowed to react at a temperature and pH
which are usually chosen from 20-80°C and 3-9 respectively.
In this case, commercially-available S-galactosidases
_g-



are appropriately used, and if necessary, ~-galactosidases can
be advantageously prepared by culturing a microorganism capable
of producing ~3-galactosidase, and recoverying S-galactosidase
from the cells or the supernatant, prior to use.
Such ~-galactosidases can be immobilized for repeated
use.
Although the neotrehalose content in the
solutions containing neotrehalose thus obtained varies
dependently on the lactoneotrehalose content in the material,
the solutions containing about 10-66% of neotrehalose, d.s.b.,
and can be usually used intact. If necessary, the solutions
can be further purified, concentrated and dried, prior, to use.
In general, in order to augment the merits of
neotrehalose, a solution containing neotrehalose is separated
and purified into a high-neotrehalose content product, prior to
use. Such separation and purification are achievable, for
example, with fermentation using yeast, membrane filtration,
fractional-sedimentation, crystalization and/or column
chromatography, as long as the concomitant saccharides are
removed therewith. In particular, a method wherein column
chromatography using strongly-acidic cation exchange resins as
disclosed in Japanese Patent Laid-Open Nos.23,799/83 and
72,598/83 can be used to remove concomitant saccharides and to
collect neotrehalose-rich fractions. In this case, either of
fixed-bed-, moving-bed- and simulated-moving-bed-methods can be
suitably employed.
_g_


Since n.eotrehalose is readily crystallizable from the
concentrate of the high-neotrehalose content solution,
crystalline neotrehalose can be advantageously prepared from
the solution, prior to use.
The process for preparing crystalline neotrehalose
according to the present invention usually contains a step of
providing a neotrehalose solution with a saturation degree of
about 1.05-4.0, more particularly, a step of preparing a
saccharide composition containing 50% or higher neotrehalose,
d.s.b., into a solution having a concentration of about 50-95%,
keeping the solution at a temperature which does not freeze the
solution and not exceed the melting point of a neotrehalose
crystal, for example, in the range of about 10-120°C.
The crystallization step usable in the invention
contains a step of placing in a crystallizer a supersaturated
neotrehalose solution which is kept at a relatively-high
temperature, i.e. 40-100°C, and gradually cooling the solution
under gentle-stirring conditions, preferably, in the presence
of 0.1-20% seed, to accelerate the crystallization. To collect
crystalline neotrehalose from the resultant masseeuite, any
conventional method is employable, as long as crystalline
neotrehalose can be obtained thereby; for example, separation-,
block-pulverization-, fluidized-bed-granulation- and spray-
drying-methods. The separation method is to separate a
massecuite into crystalline neotrehalose and the mother liquor
(molasses) using a basket-type centrifuge. If necessary, the
-10-


resultant crystalline neotrehalose can be readily washed by
spraying thereto a small amount of cool water. Thus, the
separation method can be advantageously used to prepare a
higher purity of crystalline neotrehalose. Since the other
three methods do not remove molasses, they do not improve the
purity of neotrehalose in the resultant massecuite, but realize
a high-product yield. Accordingly, the products obtained by
the three methods usually contain crystalline neotrehalose
together with other saccharide components. The saccharide
components vary dependently on the enzymatic reaction used:
For example, the components contains neotrehalose along with
galactose and glucose.
In the case of the block-pulverization method, a
massecuite having a concentration of 85-95~ and a crystallinity
of about 10-60% is usually allowed to stand for about 0.5-5
days so that the whole content is crystallized and solidified
into blocks which are then pulverized by scraping or cutting
into a reduced-hygroscopic crystalline powder containing
molasses.
In the case of the spray-drying method, a massecuite
having a concentration of 65-80~ and a crystallinity of about
20-40~ is usually spray-dried in the ventilation of a hot air,
for example, 60-100°C air which does not melt crystalline
neotrehalose, and then aged for about 1-20 hours in the
ventilation of 30-60°C air to obtain a reduced-hygroscopic
crystalline neotrehalose powder containing molasses.
-11-




2~5~~~~
The physicochemical properties of the powders, such
as melting point and specific rotation, vary dependently on the
neotrehalose content, d.s.b. Usually, the melting point
decreases and widens as the neotrehalose content lowers. The
hygroscopicity of the powders increases as the neotrehalose
content lowers. Therefore, the neotrehalose content in the
powders should be appropriately chosen to meet to their final
use.
The neotrehalose according to the present invention
is a non-reducing oligosaccharide having an extremely-high
stability and rich sweetness. The neotrehalose is metabolized
and utilized as energy source when orally administered. The
handleability of crystalline neotrehalose is satisfiable
because it is readily soluble in water and substantially free
of hygroscopicity. Since dental-caries-inducing microorganisms
only metabolize the neotrehalose at a relatively-low level, it
can be used as a sweetener with a reduced
dental-caries-inducibility. Since the neotrehalose is a
sweetener with a satisfiable stability, it can be
advantageously used as a sugar-coating agent for tablet in
combination with a binder such as pullulan and hydroxyethyl
starch. The neotrehalose has a good chemical stability, as
well as other properties such as osmosis-pressure controlling
ability, filler-imparting ability, gloss-imparting ability,
moisture-retaining ability, viscosity-imparting ability,
decreased fermentability, and crystalization-preventing ability
-12-



for other saccharides.
These merits would render the neotrehalose very
useful in the preparations of orally-administrable products,
for example, foods, beverages, cigarettes, tobaccos, feeds and
pet fr.~ods, as well as in the preparations of cosmetics and
pharmaceuticals.
The present neotrehalose can be used as a seasoning
without further treatment to impart sweetness. If necessary,
the neotrehalose can be used in combination with an adequate
amount of one or more other sweeteners, for example, starch
sugar powder, glucose, maltose, sur_rose, isomerized sugar,
honey, maple sugar, sorbitol, dihydrochalcone, steyioside,
a-glycosyl stevioside, rebaudioside, glycyrrhizin, L-aspartyl
L-phenylalanine methyl ester, saccharin, glycine and alanine.
The present neotrehalose can be mixed with a filler such as
dextrin, starch and lactose, prior to use.
The present neotrehalose in the form of powder can be
molded solely or after mixing it with filler, vehicle and/or
binder into granule, sphere, short-rod, sheet, cubic or tablet,
prior to use.
The present neotrehalose can be advantageously used
in foods and beverages in general to impart to them a sweetness
and also to improve their tastes and qualities because the
neotrehalose has a relatively-high resistance to acid and heat,
as well as having a sweetness which well harmonizes with other
substances with sour, salty, bitter, delicious and astringent.
-13-


Thus, the present neotrehalose can be advantageously
used in foods and beverages in general, for example, seasonings
such as soy sauce, say sauce powder, miso, miso powder,
"moromi", "hishio", "furikake", mayonnaise, dressing, vinegar,
"sanbai-zu", "funmatsu-sushi.-su", "chuka-no-moto", "tentsuyu"
(soup for tenpura), "mentsuyu" (soup for Japanese-style
noodles), Worcester sauce, ketchup, "yakiniku-no-tare" (soup
for grilled meat), curry roux, stew premix, soup premix,
"dashi-no "
-moto , mixed seasoning, "mirin" (heavily sweetened
sake), "shin-mirin" (synthetic mirin), table sugar and coffee
sugar.
The present neotrehalose can be advantageously used
in foods and beverages in general to impart them a sweetness
and to improve their tastes and qualities. Examples of such
foods and beverages are Japanese-style confectioneries such as
..
"senbei (rice crackers), "arare" (pellet-shaped senbe:i)
"okoshi" (millet-and rice cracker), rice paste, "manju" (bun
with a bean-jam filling), "uiro" (sweet rice jelly), "an" (bean
jam), "yokan" (sweet jelly of beans), "mizu-yokan" (soft
adzuki-bean jelly), "kingyoku", jelly, castella and "amedama"
(Japanese-style toffee); Western-style confectioneries such as
bun, biscuit, cracker, cookie, pie, pudding, butter cream,
custard cream, cream puff, waffle, sponge cake, doughnut,
chocolate, chewing gum, caramel and candy; frozen desserts such
as ice cream and sherbet; syrups such as those for fruit
preserve and °'kaki-gori" (shaved ice); pastes such as flour
-14-



~~~2~~
paste, peanut paste, fruit paste and spread; processed fruits
such as jam, marmalade, syrup-preserved fruit and crystallized
fruit; processed foods of vegetables; pickled products such as
"fukujin-nuke" (sliced vegetables picked in soy sauce),
"bettara-zuke" (fresh radish pickles), "senmai-zuke" and
"rakkyo-zuke" (pickled shallots); premixes for pickled products
such as "takuan-nuke-no-moto" and "hakusai-zuke-no-moto"; meat
products such as ham and sausage; fish meat products such as
fish meat ham, fish meant sausage, "kamaboko" (boiled fish
paste), "chikuwa" (literally bamboo wheels) and "tenpura"
(deep-fried foods); relishes such as "uni-no-shiokara" (salted
guts of sea urchin), "ika-no-shiokara" (salted guts of, squid),
"su-konbu", "saki-surume" and "fugu-no-mirinboshi"; "tsukudani"
(food boiled down in soy sauce) such as those of "nori" (dried
seaweed), "sansai" (mountain vegetables), "surume" (dried
squid), small fish and shellfish; daily dishes such as "nimame"
(cooked beans), potato salad and "konbu-maki" (tangle roll);
egg and milk products; bottled and canned products such as
those of meat, fish meat, fruit and vegetable; alcoholic drinks
such as synthetic sake, "zojo-shu", liqueur, wine a.nd whisky;
beverages such as coffee, cocoa, juice, carbonated beverage,
lactic acid beverage and lactobacillus beverage; and premixes
and instant foodstuffs such as pudding premix, hot cake premix,
"sokuseki-shiruko" (premix of adzuki-bean soup with rice cake)
and instant soup; and foods and beverages such as baby food,
beverage supplemented with nutritional ingredients, and food
-15-



2~~~~~~
for medical treatment.
The present neotrehalose can be advantageously used
in feeds and pet foods for domestic animals and poultries
including honey bee, silkworm and pet fish for the improvement
of the taste qualities of feeds and pet foods. The present
neotrehalose can be advantageously used as a sweetener, taste-
improving agent and quality-improving agent in special foods
and beverages, cosmetics and pharmaceuticals, for example,
cigar, cigarette, dentifrice, lipstick, lip cream, internal
medicine, troche, cod-liver oil drop, oral refreshing agent,
cachou and gargle in the form of a solid, paste or liquid.
As described above, the wording °'orally-administrable
products" as referred to in the invention means those which can
be orally taken or used, for example, foods, beverages,
cigarettes, tobaccos, feeds and pet foods, cosmetics and
pharmaceuticals. Any method to incorporate neotrehalose in the
orally-administrable products can be used in the invention, as
long as neotrehalose is incorporated in the products thereby
before completion of their processing. Fax example,
conventional methods such as mixing, kneading, dissolving,
melting, soaking, permeating, spreading, applying, coating,
spraying, injecting, crystallizing and solidifying are freely
chosen.
The lactoneotrehalose as material and the
neotrehalose according to the present invention will be
explained by Experiments 1 and 2 respectively.
-lb-

CA 02055255 2001-04-25
Experiment 1
Preparation of lactoneotrehalose and its physicochemical
properties
Experiment 1-1
Preparation of lactoneotrehalose
Fifty parts by weight of commercially-available
lactose and 50 parts :by weight of "PINE-DEX* #1", a dextrin
product (DE 8) commercialized by Matsutani Chemical Ind., Co.,
Ltd., Hyogo, Japan, were dissolved in 150 parts by weight of
water while heating, and the solution was heated to 60°C,
adjusted to pH 6.0, added with 300 units/g dextrin of a
cyclomaltodextrin glucanotransferase from Bacillus
stearothermophilus, commercialized by Hayashibara Biochemical
Laboratories Inc., nkayama, Japan, allowed to react for 20
hours, heated at 100°C for 15 minutes to inactivate the
remaining enzyme, cooled to 55°C, adjusted to pH 5.0-; added
with 15 units/g dext:r.in of "Glucozyme*", a glucoamylase specimen
commercialized by Nagase Biochemicals Ltd., Kyoto, Japan,
allowed to react for 16 hours, and heated at 100°C for 15
minutes to inactivate the remaining enzyme. The resultant
solution containing about 24x lactoneotrehalose, d.s.b., was
decolored with activated charcoal and treated with ion exchange
(H+- and OH -form) for deionization and purification. The
solution thus obtained was concentrated to give a concentration
of about 45~ and subjected to column chromatography, followed
by the recovery of lac:toneotrehalose-rich fractions. As the
* Trade-mark
-17-

CA 02055255 2001-04-25
fractionating resin was used "Amberlite* XT-1016 (Na'-form)", a
strongly-acidic cation exchange resin commercialized by Japan
Organo Co., Ltd., 7.'okyo, Japan, which was suspended in water
and packed in jacket:ted-stainless steel columns, inner diameter
of 5.4 cm each. Four columns, gel-bed depth of 5 m each, were
cascaded to give a total gel-bed depth of about 20 m.
While keeping the inner temperature of the columns at
55°C, 5 v/v X of a material saccharide solution was added
thereto, and 55°C water was passed through the columns at a
flow rate of SV 0.3 to effect fractionation, thus obtaining
lactoneotrehalose-rich fractions. A portion of
lactoneotrehalose-rich fractions, lactoneotrehalose content of
about 67Z, d.s.b., which had been pooled by the repetition of
the above method, was concentrated to give a concentration of
75Z, and allowed to stand overnight at 20°C to effect
crystallization. Th<= resultant crystal as seed crystal was
added to a high-lactoneotrehalose content solution, which had
been prepared by concentrating the lactoneotrehalose-rich
fractions to give a concentration of 70Z, to effect
crystallization under gentle-stirring conditions. The
resultant massecuite was separated, and the formed crystal was
sprayed with a small amount of water to obtain a high-purity
crystalline lactoneotrehalose which was then dissolved in water
and treated similarly as above to effect recrystallization.
Thus, about 3 parts by weight of a high-purity crystalline
lactoneotrehalose, purity of 99.8 or higher was obtained.
* Trade-mark
-18-


2~~5~~~
Experiment 1-2
Ph sicochemical properties of 1 a~finnont,-.,t..,,
a...u.c11a1V$e
The physicochemical properties of lactoneotrehalose
were studied with a high-purity crystalline lactoneotrehalose
specimen prepared by the method in Experiment 1-1.
(1) Elemental analysis
Found; C=42.8%, H=6.4%, 0=50.8%
Calculated; C=42.86%, H=6.39%, 0=50.75%
(for chemical formula C18H32016)
(2) Molecular weight
504.4
(3) Melting point
168.5-169.0°C
(4) Specific rotation
fa)D =+82.6° (c=2.0, H20)
(5) uv-Absorption spectrum
Exhibiting no characteristic uv-absorption when
tested in water.
(6) Infrared absorption spectrum
Two mg of the crystal and 200 mg of dried KBr
were mixed by stirring to obtain about 0.6 mm
thick transparent tablet, and the infrared
spectrum of the crystal was determined
therewith. The result was shown in FIG. I.
(7) Solubility
21.7 g of the crystal dissolves in 100 g water
_19_




2~5~~5~
at 25°C.
(8) Heat of dissolutiOTl
20.0 cal/g
(9) Physical properties and color
Colorless and transparent crystal having a true
specific gravity of 1.59. Pulverized crystal
has a favorable taste and about 1/4 sweetening
power of sucrose and exhibits a white
appearance, but exhibits no odor. Free of
hygroscopicity and deliquescence.
The Karl Fischer's method revealed that the
moisture content of crystals predried _in vacuo
at 60°C for 16 hours is less than 3.0% FIG.2
shows a microscopic photograph of a crystal
obtained by crystallization in an aqueous
solution. An aqueous solution of the crystal
shows neutral or slight acidity.
(I0) Solubility in solvents
Readily soluble in water, O.1N sodium hydroxide,
and O.1N hydrochloric acid; scarcely soluble in
methanol and ethanol; and insoluble in
chloroform and ethyl acetate.
(11) Coloring reaction
Turning green on the anthrone-sulfuric acid
reaction.
Negative to both the Fehling's reaction and the
-20-



iodine coloration :reaction.
(12) Structure
(a) Hydrolysis with 1N-sulfuric acid gives 2
moles of D-glucose and one mole of D-
galactose.
(b) Gas chromatographic analysis on saccharides
obtained by acetylating the crystal with
methylhexytol revealed that the crystal
formed one mole of 1,5-di-0-acetyl-2,3,4,6-
tetra-0-methylglucitol, one mole of 1,5-di-
0-acetyl-2,3,4,6-tetra-0-methylgalactitol,
and one mole of 1,4,5-tri-0-acetyl-2,3,6-
tri-0-methylglucitol.
(c) Infrared absorption spectrum of the crystal
gives the absorption near at RlOcm 1
inherent to S-D-galactopyranosyl bond, the
absorption near at 880-875 cm 1 inherent to
6-D-glucopyranosyl bond, and the absorption
near at 860-840 cm 1 inherent to a-D-
glucopyranosyl bond.
(d) den subjected to the action of
galactosidase, D-galactose and neotrehalose
are formed.
(e) When subjected to the action of a-
glucosidase, D-glucose and lactose are
formed.
_~1_



~~~~?5
(f) On carbon-13 nuclear magnetic resonance
(13C-~R) analysis, eighteen 13C signals
were observed and all of eighteen carbons
of the crystal showed dif:Eerent chemical
shifts respectively. Based on the chemical
shifts of S-D-galactopyranose, S-D-
glucopyranose and a-D-glucopyranose as the
standard substances reported in J. H,
Bradbury et al., Carbohydrate Research,
Vo1.126, pp.125-156 (1984), each carbon of
the crystal is assigned to reveal that the
crystal has the structure of 0-~-D-
galactopyranosyl-(1-~4)-0-S-D-glucopyranosyl
a-D-glucopyranoside.
Based on the above results, the chemical structure of
the crystal can be shown as follows:
HOCHz
0
H g H a~
HO OH H
:n
i
H OH v
0
HOCHs HOCHz
0 i a
HO.~ H 0
p H v
H OH H H. OH H H
i
H OH r
H OH
Lactose
Structure of the crystal (lactoneotrehalose)
-22-

CA 02055255 2001-04-25
Based on the above structure, the substance
according to the invention is named as lactoneo-
trehalose.
(13) Powder x-ray diffraction analysis
The powder x-ray diffraction pattern of a
crystalline lactoneotrehalose specimen was
determined with "GEIGERFLEX RAD-IIB* (CuKa ray)",
a product of Rigaku Corp., Tokyo, Japan. The
results were shown in FIG.3. As evident from
FIG.3, the crystalline lactoneotrehalose
exhib:Lts predominant diffraction angles (2e) of
12.8°, 18.1°, 19.2°, 19.7° and 24.2° on
powder
x-ray diffraction analysis.
Experiment 2
Preparation and physicochemical properties of neotrehalose
Experiment 2-1
Preparation of neotrehalose
One part by weight of a crystalline lactoneotrehalose
specimen obtained by the method in Experiment 1-1 was dissolved
in 30 parts by weight of water while heating, adjusted to 40°C
and pH 4.5, added 10 units/g lactoneotrehalose of "LACTASE-LP*",
a S-galactosidase :>pecimen commercialized by K~I Chemical
Industry, Co. , Ltd. , Shizuoka, Japan, allowed to react for 20
hours, and heated a1. 100°C for 10 minutes to inactivate the
remaining enzyme. Similarly as in Experiment 1-1, the
resultant solution containing about 66x neotrehalose and about
* Trade-mark
-23-




33% galactose, d.s.b., was decolored, deionized, purified,
concentrated, and subjected to column chromatography using a
strongly-acidic cation exchange resin, followed by the recovery
of neotrehalose-rich fractions.
A part of the neotrehalose-rich fractions containing
about 88% neotrehalose, d.s.b., was concentrated to give a
concentration of 75%, and allowed to stand overnight at 20°C to
effect crystallization. The resultant crystal was added as
seed to a solution having a concentration of 70% which had been
prepared by concentrating the neotrehalose-rich fractions, and
allowed to effect crystallization under gentle stirring
conditions. The resultant massecuite was separated, and the
formed crystal was washed by spraying thereto a small amount of
water to obtain a high-purity crystal which was then dissolved
in water and recrystallized similarly as above to obtain about
0.15 parts by weight of a high-purity crystalline neotrehalose,
purity of 99.8% or higher.
Experiment 2-2
Physicochemical properties of neotreha7n~P
The physicochemical properties of neotrehalose were
studied with a high-purity crystalline neotrehalose specimen
prepared by the method in Experiment 2-1.
(1) Elemental analysis
Found; C=40.0%, H=6.7%, 0=53.3%
Calculated; C=40.00%, H=6.71%, 0=53.29%
(for chemical formula C12H22011°H20)
-24-

~~~~~~5
(2) Molecular weight
360.3
(3) Melting point
144.5-145°C
(4) Specific rotation
falDO=+93.9° (c=2.0, H2p)
(5) uv-Absorption spectrum
Exhibiting no characteristic uv-absorption when
tested in water.
(6) Infrared absorption spectrum
Two mg of the crystal and 200 mg of dried KBr
were mixed by stirring to obtain about 0.6 mm
thick transparent tablet, and the infrared
spectrum of the crystal was determined
therewith. The result was shown in FIG.4.
(7) Solubility
Fifty-five g of the crystal in the form of
anhydride dissolves in 100 g water at 25°C,
(8) Physical properties and color
Colorless and transparent crystal. Pulverized
crystal has a favorable taste and about 1/3
sweetening power of sucrose and exhibits a white
appearance, but exhibits no odor. Free of
hygroscopicity and deliquescence.
The Karl Fischer's method revealed that the
moisture content of crystals predried in vacuo
-25-


at 60°C for 16 hours is less than 5.2%, and this
showed that the crystal was a monohydrate
crystal. FIG S shows a microscopic photograph
of a crystal obtained by crystallization in an
aqueous solution. An aqueous solution of the
crystal shows neutral or slight acidity.
(9) Solubility in solvents
Readily soluble in water, O.1N sodium hydroxide,
and O.1N hydrochloric acid; scarcely soluble in
methanol and ethanol; and insoluble in
chloroform and ethyl acetate.
(10) Coloring reaction
Turning green on the anthrone-sulfuric acid
reaction.
Negative to both the Fehling's reaction and the
iodine coloration reaction.
(11) Structure
(a) Hydrolysis with 1N-sulfuric acid gives 2
moles of D-glucose per one mole of the
crystal.
(b) Gas chromatographic analysis on saccharides
obtained by acetylating the crystal with
methylhexytol revealed that the crystal
consisted of 1,5-di-p-acetyl-2,3,4,6-
tetra-0-methylglucitol, and this confirmed
that the glucose molecules in the crystal
-26-


were bound at the C-1 position of each
glucose molecule.
(c) Infrared absorption spectrum of the crystal
gives the absorption near at 880 cm-1
inherent to S-D-glucopyranosyl bond, and
the absorption near at 840 cm 1 inherent to
a-D-glucopyranosyl bond.
(d) den subjected to the action of a-
glucosidase, D-glucose is formed, but not
hydrolyzed by trehalase.
Based on the above results, the chemical structure of
the crystal can be shown as follows:
HOCHz
g 0
H H
HO OH H
H off
0
HOCHz
g 0
H
OH OH H H
H OH
Structure of the crystal (neotrehalose)
-27-

CA 02055255 2001-04-25
(12) Powder x-ray diffraction analysis
The powder x-ray diffraction pattern of a
crystalline neotrehalose specimen was determined
with '°GEIGERFLEX RAD-IIB* (CUKa ray)", a product
of IZigaku Corp., Tokyo, Japan. The results were
shown in FIG.6.
As evident from FIG.6, the crystalline
neotrehalose exhibits predominant diffraction
angles (2e) of 9.3°, 15.8°, 18.9°, 20.6° and
22.7° on powder x-ray diffraction analysis.
Experiment 2-3
Digestion test
In accordance with the method described in H. Atsuji
et al., Journal of Clinical Nutrition, Vo1.41, Vol.2,
pp.200-208 (1972), the load test by orally-administering to
healthy volunteers a crystalline neotrehalose specimen prepared
by the method in Experiment 2-1 was done, and their bloods were
sampled at prescribed time intervals and subjected to the
measurements of the blood sugar and insulin levels. As
control, glucose was used.
As a result, neotrehalose behaved similarly as
glucose, and the maximum levels of blood sugar and insulin
showed about 0.5-1 hour after the administration.
This confirmed that neotrehalose was readily
digested, absorbed, metabolized and utilized into energy.
* Trade-mark
-28-

CA 02055255 2001-04-25
Experiment 2-4
Acute toxicity
A crystalline neotrehalose specimen, prepared by the
method in Experiment 2-1, was orally administered to 7 week-old
dd mice for acute toxicity test. As a result, no animal death
was noted with the administration of up to S g of the specimen
and higher dose was difficult to do.
Therefore, the toxicity of the tested substance
appears to be extremE~:ly low.
Examples for reference and Examples A will illustrate
the preparations of lactoneotrehalose and the neotrehalose
according to the present invention; and Examples B, the orally-
administrable product=s according to the present invention.
Example for reference 1
One part by weight of lactose and 2 parts by weight
of "PINE-DEX* #4", a dextrin product (DE 18) commercialized by
Matsutani Chemical Ind., Co., Ltd., Kyoto, Japan, were
dissolved in 3.7 parts by weight of water while heating, and
the solution was heat:ed to 60°C, adjusted to pH 5.6, added with
300 units/g dextrin of a cyclomaltodextrin glucanotransferase
specimen commercialized by Hayashibara Biochemical
Laboratories, Inc., Ukayama, Japan, allowed to react for 20
hours, and heated t.o inactivate the remaining enzyme. The
resultant mixture was in an usual manner decolored with
activated charcoal, deionized, purified and concentrated into a
syrup having a concentration of 75Z in the yield of about 92Z,
* Trade-mark
-29-




d.s.b.
The product containing about 15% lactoneotrehalose,
d.s.b,, exhibits a moderate sweetness, appropriate viscosity
and moisture-retaining ability, and these render the product
very useful in orally-administrable products.
Example for reference 2
One part by weight of lactose and 1.5 parts by weight
of a-cyclodextrin were dissolved in 4 parts by weight of water
while heating, and the solution was first heated to 65°C,
adjusted to pH 5.6, added with 200 units/g dextrin of fresh
cyclomaltodextrin glucanotransferase as used in Example for
reference l, and allowed to react for 24 hours. Thereafter,
the resultant solution was heated to inactivate the remaining
enzyme, cooled to 55°C, adjusted to pH 5.6, added with 10
units/g dextrin of "~-amylase ~~1500", a S-amylase specimen
commercialized by Nagase Biochemicals Ltd., Kyoto, Japan, and
allowed to react for 16 hours. After completion of the
reaction, the mixture was heated to inactivate the remaining
enzyme. Similarly as in Example for reference 1, the resultant
mixture was purified and concentrated into a syrup having a
concentration of 75% in the yield of about 93%, d.s.b.
The product containing about 25% lactoneotrehalose,
d.s.b., exhibits a moderate sweetness, appropriate viscosity
and moisture-retaining ability, and these render the product
very useful in orally-administrable products similarly as the
product in Example for reference 1.
-30-



Example for reference 3
To a starch slurry, concentration of 20%, was added
0.15% of "Termamyl~ 60L", an a-amylase specimen commercialized
by Novo Industri Japan, Ltd., Tokyo, Japan, against starch,
d.s.b., and the mixture was heated to a temperature in the
range of 95-100°C to effect liquefaction, and further heated to
inactivate the remaining enzyme to obtain a liquefied solution
(DE 3) which was then added with lactose equivalent to the
amount of amylaceous substance contained in the liquefied
solution, d.s.b. The resultant mixture was heated to 55°C,
adjusted to pH 5.3, added with 50 units/g starch of an
isoamylase specimen commercialized by Hayashibara Biachemical
Laboratories Inc., Okayama, Japan, together with 300 units/g
starch of the same cyclomaltodextrin glucanotransferase as used
in Example fox reference 1, and allowed to react for 24 hours.
Thereafter, the mixture thus obtained was heated to inactivate
the remaining enzyme, diluted with water to give a
concentration of about 25%, heated to 55°C, adjusted to pH 5.3,
added with 15 units/g dextrin of glucoamylase, allowed to react
for 16 hours, and further heated to inactivate the remaining
enzyme. Similarly as in Example for reference 1, the solution
thus obtained was purified and concentrated into a syrup having
a concentration of 75% in the yield of about 90%, d.s.b.
The product containing about 34% lactoneotrehalose,
d.s.b., exhibits a moderate sweetness, appropriate viscosity
and moisture-retaining ability, and these render the product
-31-




very useful in orally-administrable products similarly as the
product in Example for reference 1.
Example for reference 4
To a liquefied solution (DE 3) prepared by the method
in Example for reference 3 was dissolved 2-fold amounts of
lactose against the amylaceous substance in the liquefied
solution, d.s.b. The mixture was heated to 60°C, adjusted to
pH 5.b, added with 100 units/g dextrin of cyclomaltodextrin
glucanotransferase, allowed to react for 48 hours, and heated
to inactivate the remaining enzyme. Similarly as in Example
for reference 3, the resultant mixture was added with
glucoamylase to effect an enzymatic reaction and heated to
inactivate the remaining enzyme. Similarly as in example for
reference 1, the resultant solution was purified and
concentrated into a syrup, concentration of 75%, which was then
transferred to a crystallizer to effect crystallization by the
addition of a small.amount of crystalline lactose. Thereafter,
the mixture was centrifuged to remove crystalline
lactoneotrehalose and the resultant solution was concentrated
into a syrup having a concentration of 75% in the yield of
about 70%, d.s.b.
The product containing about 35% lactoneotrehalose,
d.s.b., exhibits a moderate sweetness, appropriate viscosity
and moisture-retaining ability, and these render the product
very useful in orally-administrable products similarly as the
product in Example for reference 1.
_32_

CA 02055255 2001-04-25
Example A-1
A solution containing about 15Z lactoneotrehalose,
d.s.b., prepared by t:he method in Example for reference 1, was
concentrated. to give a concentration of 45Z, and the resultant
was heated to 40°C, adjusted to pH 4.5, added with 15 units/g
lactoneotrehalose of '"LACTASE-LP*", a ~3-galactosidase specimen,
allowed to react for 24 hours, and heated to inactivate the
remaining enzyme.
The result=ant solution was decolored in an usual
manner with activated charcoal, deionized with ion-exchange
resins (H+ and OH foam), purified and concentrated into a syrup
having a concentration of 75~ in the yield of about 92Z, d.s.b.
The product containing about 10% neotrehalose,
d.s.b., exhibits a rich sweetness, appropriate viscosity and
moisture-retaining ability, and these render the product very
useful in orally-adm:inistrable products.
Example A-2
A solution; containing about 25x lactoneotrehalose,
d.s.b., prepared by the method in Example for reference 2, was
concentrated to give a concentration of about 40Z, and the
resultant was heated to 45°C, adjusted to pH 7.2, added with 10
units/g lactoneotreh~3lose of "LACTOZYME* 3000L", a
S-galactosidase specimen commercialized by Novo Industri Japan,
Ltd., Tokyo, Japan, allowed to react for 20 hours, and heated
to inactivate the remaining enzyme.
Similarly .as in Example A-l, the resultant solution
* Trade-mark
-33-




was purified and concentrated into a syrup having a
concentration of 75% in the yield of about 93%, d.s.b.
Similarly as the product in Example A-1, the product
containing about 16% neotrehalose, d.s.b., exhibits a rich
sweetness, appropriate viscosity and moisture-retaining
ability, and these render the product very useful in orally-
administrable products.
Example A-3
A solution containing about 34% lactoneotrehalose,
d.s.b., prepared by the method in Example for reference 3, was
concentrated to give a concentration of about 35%, and the
resultant solution was heated to 40°C, adjusted to pH 4.5,
added with ~-galactosidase similarly as in Example A-1, allowed
to react, and heated to inactivate the remaining enzyme.
Similarly as in Example A-1, the solution thus
obtained was purified and concentrated into a syrup having a
concentration of 75% in the yield of about 94%, d.s.b.
Similarly as the product in Example A-l, the product
containing about 22% neotrehalose, d.s.b., exhibits a rich
sweetness, appropriate viscosity and moisture-retaining
ability, and these render the product very useful in orally-
administrable products.
Example A-4
A solution containing about 35% lactoneotrehalose,
d.s.b., prepared by the method in Example for reference 4, was
concentrated to give a concentration of about 35%, and the
-34-

CA 02055255 2001-04-25
resultant solution was heated to 45°C, adjusted to p H 7.2,
added with S-galactosidase similarly as in Example A-2, allowed
to react, and heated to inactivate the remaining enzyme.
Similarly as in Example A-1, the solution thus
obtained was purified and concentrated into a syrup having a
concentration of 75x in the yield of about 94X, d.s.b.
Similarly as the product in Example A-1, the product
containing about 22X neotrehalose, d.s.b., exhibits a rich
sweetness, appropriate viscosity and moisture-retaining
ability, and these render the product very useful in orally-
administrable products.
Example A-5
A solution containing about 66x neotrehalose, d.s.b.,
prepared by using the reaction- and purification-methods in
Experiment 2-1, as a material saccharide solution, was
concentrated to give a concentration of about 45x. In order to
higher the neotrehalose content in the resultant solution,
which was subjected to column chromatography similarly as the
method in Experiment 1-1 except that "DOWEX* 50Wx4 (Ca"-form)",
a strongly-acidic cation exchange resin commercialized by Dow
Chemical Company, Midland, Michigan, USA, was used as a resin
for fractionation to obtain a neotrehalose-rich fraction
containing about 85',Z neotrehalose, d.s.b. The fraction was
concentrated to give a concentration of about 83X, and the
resultant solution was transferred to a crystallizer and
admixed with an about one x seed. The mixture was transferred
* Trade-mark
-35-

~,~ww~~
/, 'La .~ .~ ;., ?., i",9
to a tray and allowed to stand at 20°C for 4 days to effect
crystalization and solidification. Thereafter, the resultant
solid was pulverized with a cutting-type pulverizer and dried
to obtain a crystalline neotrehalose powder containing molasses
in the yield of about 70%, d.s.b.
The product is readily handleable and substantially
free of hygroscopicity, and these render the product very
useful in orally-administrable products as a sweetener,
stabilizer, taste-improving agent and quality-improving agent.
Example A-6
In order to higher the neotrehalose content in an
about 22% high-neotrehalose content solution, d.s.b., ,prepared
by using the reaction- and purification-methods in Example A-5,
as a material saccharide solution, was subjected to column
chromatography according to the method in Example A-5 to
obtain a neotrehalose-rich fraction containing about 75~
neotrehalose, d.s.b. The fraction was concentrated to give a
concentration of about 77%, transferred to a crystallizer,
added with an about 27 seed, and gradually cooled to obtain a
massecuite having a crystallization degree of about 35~, which
was then sprayed through a nozzle equipped at the top of a
spraying tower with a pressure of 150kg/cm2. Simultaneously,
85°C air was passed from the top of the tower towards a net
conveyer, provided at the bottom of the tower, to collect the
pulverized product on the net conveyer and also to gradually
carry the resultant crystalline powder out of the tower while
-36-



passing a stream of ~~5°C air upwards through the net conveyer.
The crystalline powder was then placed in an ageing tower and
aged for 10 hours to effect crystallization and dehydration.
Thus, a crystalline neotrehalose powder containing molasses was
obtained in the yield of about 25%, d.s.b.
The product is readily handleable and substantially
free of hygroscopicity, and these render the product very
useful in orally-administrable products as a sweetener,
stabilizer, taste-improving agent and quality-improving agent.
Example A-7
An about 66% high-neotrehalose content solution,
d.s.b., prepared by using the reaction- and purification
methods in Experiment 2-l, as a material saccharide solution,
was concentrated to give a concentration of about 75%, In
order to higher the neotrehalose content in the resultant
solution, which was transferred to a crystallizer, added with
an about one % of a powdery seed, and gradually cooled to
effect crystallization under stirring conditions. Thereafter,
the resultant mixture was subjected to separation with a
basket-type centrifuge to obtain a crystal which was then
washed by spraying thereto a small amount of water. Thus, a
high-purity crystalline neotrehalose was obtained in the yield
of about 35%, d.s.b.
The product exhibits the same physicochemical
properties as the product in Experiment 2-2, and these render
the product very useful in orally-administrable products as a
-37-

CA 02055255 2001-04-25
sweetener, stabili2:er, taste-improving agent and quality-
improving agent. The product can be also used in industrial
reagents and chemical materials.
Example B-1
One part 1>y weight of a crystalline neotrehalose
obtained by the method in Example A-6 was mixed to homogeneity
with 0.05 parts by weight of "a-G sweet*", an a-glycosyl
stevioside product commercialized by Toyo Sugar Refining Co.,
Ltd., Tokyo, Japan, and the mixture was subjected to a
granulator to obtain a sweetener in the form of granule.
Since the sweetener has a satisfiable quality of
sweetness and an about 2-fold higher sweetening power of
sucrose, the calorific value of the sweetener lowers to about
half of that of sucrose per sweetening power.
The sweetener can be advantageously used as a low-
caloric sweetener in low-caloric foods and beverages for
overweight persons and diabetics who are restricted to a diet.
Since caries-inducing microorganisms less form acids
and insoluble glucans when administered the sweetener, the
sweetener can be favorably used as a sweetener in caries-
preventing foods and beverages.
Example B-2
Hard candy
One hundred parts by weight of a 55Z sucrose solution
and 30 parts by weight of a syrup containing neotrehalose,
* Trade-mark
-38-


obtained by the method in Example A-2, were mixed by heating.
Thereafter, the mixture was concentrated by heating _in vacuo
until the moisture content decreased to lower than 2%, and
further admixed with one part by weight of citric acid and
adequate amounts of a coloring agent and lemon flavor. The
resultant mixture was formed into the captioned product in an
usual manner.
The product is a high-quality hard candy having a
satisfiable taste and biting property, wherein the crystalliza-
tion of sucrose is prevented.
Example B-3
Strawberry jam
One hundred and fifty parts by weight of strawberry,
60 parts by weight of sucrose, 20 parts by weight of maltose,
40 parts by weight of a syrup containing neotrehalose obtained
by the method in Example A-4, 5 parts by weight of pectin and
one part by weight of citric acid were boiled up in a vessel
and the mixture was bottled into the captioned product.
The product is a favorable strawberry jam having a
satisfiable flavor and color.
Example B-4
Eactic acid beverage
Ten parts by weight of defatted mills was sterilized
by heating at 80°C for 20 minutes, cooled to 40°C, added with
0.3 parts by weight of a starter, and fermented at about 37°C
for 10 hours. Thereafter, the mixture was homogenized and
-39-


added with 4 parts by weight of a crystalline neotrehalose
powder obtained by the method in Example A-5, one part by
weight of sucrose, and 2 parts by weight of an isomerized
syrup. The resultant mixture was sterilized at 70°C, cooled,
added with an adequate amount of a flavoring agent, and bottled
to obtain the captioned product.
The product is a high-quality lactic acid beverage
having a sour taste which is satisfactorily harmonized with
flavor and sweetness.
Example B-5
Sweetened condensed milk
To 100 parts by weight of milk was dissolved one part
by weight of sucrose and 3 parts by weight of a syrup
containing neotrehalose obtained by the method in Example A-1,
and the mixture was sterilized by heating with a plate heater,
concentrated to give a concentration of about 70~, and
aseptically canned to obtain the captioned product.
The product has a moderate sweetness and a
satisfiable flavor, and these render the product very useful as
seasoning in foods for baby and infant, fruit, coffee, cocoa
and tea.
Example B-6
-
Fruit-iuice powder
Thirty-three parts by weight of pulverized orange
juice prepared by spray-drying was stirred and mixed to
homogeneity with 50 parts by weight of a crystalline neo-
-40-

?~ ~~~:~
trehalose obtained by the method in Example A-7, 10 parts by
weight of sucrose, 0.65 parts by weight of anhydrous citric
acid, 0.1 part by weight malic acid, 0,1 part by weight of
L-ascorbic acid, 0.1 part by weight of sodium citrate, p,5
parts by weight of pullulan, and an adeduate amount of a
powdery flavoring agent. The mixture was pulverized, and the
resultant powder was fed to a fluidized-bed granulator and
granulated at an inlet temperature of 40°C and an air-flow-rate
of 150m3/min for 30 minutes while spraying the content with a
high-neotrehalose content solution, obtained by the method in
Example A-5, as a binder. Thereafter, the resultant was
weighed and packaged to obtain the captioned product.
The product is a fruit-juice powder having an orange
juice content of about 30~, The product is free of an
unfavorable taste and odor, and stable over a relatively long
period of time without being solidified by absorbing moisture.
Example B-7
Chocol-to
Forty parts by weight of cacao paste, 10 parts by
weight of cacao butter, and 50 parts by weight of a crystalline
neotrehalose obtained by the method in Example A-7 were mixed,
and the mixture was fed to a refiner to reduce the particle
size, transferred to a conche, and kneaded therein at 50°C for
2 days. In the kneading step, 0.5 parts by weight of lecithin
was added and dispersed to homogeneity. Thereafter, the
content was adjusted to 31°C with a thermoregulator, and placed
-41--



~~3~~~~
in a mold immediately before the solidification of the butter,
deaerated with a vibrator, and solidified by passing it through
a 10°C cooling tunnel over a period of 20 minutes. The content
was removed from the mold and packaged to obtain the captioned
product.
The product with an excellent color, gloss and
texture exhibits no hygroscopicity and smoothly melts in the
mouth to exhibit a moderate sweetness and smooth flavor.
Example B-g
Chewing um
Three parts by weight of a gum base was melted by
heating until it softened, and admixed with 4 parts by weight
of sucrose, 3 parts by weight of a crystalline neotrehalose
powder obtained by the method in Example A-6, and adequate
amounts of a flavoring agent and coloring agent. The mixture
was kneaded with a roll in an usual manner, formed and packaged
to obtain the captioned product.
The product is a favorable chewing gum having a
satisfiable texture and flavor.
Example B-9
Custard cream
One hundred parts by weight of corn starch, 100 parts
by weight of a syrup containing neotrehalose obtained by the
method in Example A-4, 80 parts by weight of maltose, 20 parts
by weight of sucrose, and one part by weight of salt were mixed
to homogeneity. The mixture was admixed with 280 parts by
-42-


weight of eggs and gradually added with 1, 000 parts by weight
of a boiling milk. The resultant mixture was heated while
stirring, and the heating was stopped when the whole content
turned semi-transparent. Thereafter, the resultant product was
cooled and added with an adequate amount of vanilla flavor, and
the mixture was weighed, filled up and packaged to obtain the
captioned product.
The product has a smooth gloss, moderate sweetness
and satisfiable taste.
Example B-10
"Uiro-no-moto" premix of sweet rice Telly)
An uiro-no-moto was prepared by mixing to homogeneity
90 parts by weight of rice powder, 20 parts by weight of corn
starch, 120 parts by weight of a crystalline neotrehalose
powder obtained by the method in Example A-5, and 4 parts by
weight of pullulan. The mixture was kneaded with adequate
amounts of "matcha" (powdered green tea) and water, and the
resultant mixture was placed in a vessel and steamed up over a
period of 60 minutes to obtain an uiro containing matcha.
The product has a satisfiable gloss, biting-property
and flavor. The shelf-life of the product is relatively long
because the retrogradation of starch in the product is
inhibited.
Example B-11
interferon tablet
A natural human interferon-a specimen produced by
-43-

. P.,
Hayashibara Biochemical Laboratories Inc., Okayama, Japan, and
commercialized by Cosmo Bio Co., Ltd., Tokyo, Japan, was
subjected in an usual manner to column chromatography using an
immobilized anti-human interferon-a antibody to adsorb thereto
the human natural interferon-a contained in the specimen, as
well as to remove calf serum-albumin as a stabilizer by passing
it though the column. Thereafter, the pH in the column was
changed, and the natural human interferon-a was eluted from the
column with a physiological saline containing 5% of a crystal-
line neotrehalose specimen obtained by the method in Example
A-~~ ?he resultant solution was membrane-filtered, and the
filtrate was dehydrated and pulverized by the addition of
20-fold volumes of "FINETOSE~", an anhydrous crystalline
maltose powder commercialized by Hayashibara Shoji Inc.,
Okayama, Japan, and the resultant powder was tabletted with a
tabletting machine to obtain the captioned product containing
about 150 units/tablet of natural human interferon-a, about 200
mg each.
In use, the product is orally-administered to the
adult in an amount of 1-10 tablets/day/adult as a sublingual
tablet, and can be advantageously used in the treatment of
viral diseases, allergic diseases, rheumatism, diabetics and
malignant tumors. More particularly, the product can be
advantageously used as a therapeutic agent for patients suf-
fering from acquired immune deficiency syndrome (AIDS) and
hepatitis, the number of which has been extremely increased
-44-


recently.
Since neotrehalose and maltose act as stabilizer, the
activity of the product is retained for a relatively long
period o:E time even when allowed to stand at ambient
temperature.
Example B-12
Sugar-coated tablet
A plain tablet (150 mg in weight) as a core tablet
was coated with the first sugar-coating composition consisting
of 40 parts by weight of a crystalline neotrehalose specimen
obtained by the method in Example A-7, 2 parts by weight of
pullulan (average molecular weight of 200,000), 30 parts by
weight of water, 25 parts by weight of talc and 3 parts by
weight of titanium oxide until the tablet weighed about 230 mg.
Thereafter, the resultant tablet was first coated with the
second sugar-coating composition consisting of 65 parts by
weight of the same crystalline neotrehalose as used in the
above, one part by weight of pullulan (average molecular weight
of 200,000) and 34 parts by weight of water, then coated with a
wax solution to impart a gloss. Thus, the captioned product
having a gloss and satisfiable appearance was obtained.
The handleability in the sugar-coating step for the
product is satisfactory, and the product has a satisfiable
shock-resistance and retains its quality at a relatively
high-level over a relatively long period of time.
-45-

[Effect of the invention]
As described above, the present neotrehalose prep aced
by allowing ~-galactosidase to act on lactoneotrehalose is
obtained in a relatively high-yield: The separation- and
purification-processes of the neotrehalose are facilitated.
The neotrehalose is a non-reducing oligosaccharide having a
satisfiable stability and a rich- and high-quality-sweetness.
The neotrehalose is metabolized and utilized as energy source
when orally administered. The neotrehalose in the form of
crystal has a satisfiable handleability because it is readily
soluble in water and substantially free of hygroscopicity.
The neotrehalose has merits, for example, a
satisfiable chemical-stability, osmosis-pressure controlling
ability, activating ability, gloss-imparting ability, moisture-
retaining ability, viscosity-imparting ability, decreased
fermentability, and crystallization-preventing ability for
other saccharides. fihese render neotrehalose very useful in
the preparations of orally-administrable pxoducts.
Accordingly, the establishment of the present
preparation of neotrehalose and its uses have a great
significance in the fields of food-, cosmetic- and
pharmaceutical-industries.
While there has been described what is at present
considered to be the preferred embodiments of the invention, it
will be understood that various modifications may be made
-46-


~''~~'~3~:~ ~o
therein, and it is intended to cover in the appended claims all
such modifications as fall within the true spirit and scope of
the invention.
-47-

Representative Drawing

Sorry, the representative drawing for patent document number 2055255 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2002-09-03
(22) Filed 1991-11-12
(41) Open to Public Inspection 1992-05-16
Examination Requested 1998-08-12
(45) Issued 2002-09-03
Deemed Expired 2006-11-14

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1991-11-12
Registration of a document - section 124 $0.00 1992-06-05
Maintenance Fee - Application - New Act 2 1993-11-12 $100.00 1993-11-10
Maintenance Fee - Application - New Act 3 1994-11-14 $100.00 1994-11-14
Maintenance Fee - Application - New Act 4 1995-11-13 $100.00 1995-11-10
Maintenance Fee - Application - New Act 5 1996-11-12 $150.00 1996-11-06
Maintenance Fee - Application - New Act 6 1997-11-12 $150.00 1997-09-18
Request for Examination $400.00 1998-08-12
Maintenance Fee - Application - New Act 7 1998-11-12 $150.00 1998-09-09
Maintenance Fee - Application - New Act 8 1999-11-12 $150.00 1999-09-02
Maintenance Fee - Application - New Act 9 2000-11-13 $150.00 2000-07-31
Maintenance Fee - Application - New Act 10 2001-11-12 $200.00 2001-07-25
Final Fee $300.00 2002-06-20
Maintenance Fee - Patent - New Act 11 2002-11-12 $200.00 2002-08-16
Maintenance Fee - Patent - New Act 12 2003-11-12 $200.00 2003-07-30
Maintenance Fee - Patent - New Act 13 2004-11-12 $250.00 2004-07-26
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
Past Owners on Record
CHAEN, HIROTO
MIWA, YOSHIKATSU
SHIBUYA, TAKASHI
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 2002-07-30 1 31
Description 2001-04-25 47 1,502
Description 1994-01-20 47 1,521
Cover Page 1994-01-20 1 16
Abstract 1994-01-20 1 19
Claims 1994-01-20 2 58
Drawings 1994-01-20 6 192
Claims 2001-04-25 2 71
Assignment 1991-11-12 8 261
Prosecution-Amendment 1998-08-12 1 39
Prosecution-Amendment 2001-05-18 1 23
Prosecution-Amendment 2001-05-28 2 74
Prosecution-Amendment 2001-04-25 16 522
Correspondence 2002-06-20 1 34
Prosecution-Amendment 2000-12-28 3 101
Fees 1996-11-06 1 50
Fees 1995-11-10 1 46
Fees 1994-11-14 1 43
Fees 1993-11-10 1 29